Device Trial Radar · NCT07920341
Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Nov 4, 2026
Primary completion
Nov 4, 2027
Study completion Nov 4, 2027
Sponsor
- Lead sponsor
- University of the PacificAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 5, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a clinical trial looking at differences in continuous glucose monitor (CGM) glucose readings between the left and right arms in adults with type 1 or type 2 diabetes. The study will enroll 60 participants who will wear a CGM sensor on both arms for 14 days.
Conditions
- Continuous Glucose Monitoring
- Type 1 Diabetes
- Type 2 Diabetes
Interventions
FreeStyle Libre 3 Plus Continuous Glucose MonitorDevice
Two FreeStyle Libre 3 Plus continuous glucose monitors (CGMs) will be worn simultaneously for 14 days. One sensor will be applied subcutaneously to the back of the upper arm on each arm. The sensors measure glucose in the interstitial fluid, and data from the left and right arms will be collected and compared.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Difference in Frequency of Hypoglycemic Events Between Left and Right ArmsTime frame: 14 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of the Pacific
Stockton, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.